Results about: Alzheimer’s Disease

Modern molecular and cell biology no longer focus only on single macromolecules but now look into pathways, complexes or even entire organisms.

New strategy to obtain a specific type of amyloid-beta aggregate that may underlie neuronal death in Alzheimer’s disease

Researchers at IRB Barcelona describe for the first time how to prepare a specific type of aggregate of the amyloid-beta protein with the ability to perforate the cell membrane.

What causes neuron death and the subsequent cognitive decline in Alzheimer´s disease is still unknown.

Researchers discover the machinery that neurons use to form and maintain their neuronal extensions

The study, led by IRB Barcelona and published in Nature Communications will help research into regenerative medicine and potentially also help understand neurodegenerative diseases such as Alzheimer’s.

Looking for the ‘magic drug’ to fight Alzheimer’s and diabetes

Turkish-born Emre Güney (Izmir, 1983) joined IRB Barcelona in October 2015 as a Beatriu de Pinós Postodoctoral Fellow. Supporting the best young scientists, these highly competitive 2-year fellowships awarded by the Catalan Government allow them to choose the centre where they want to carry out their research project.

Pardridge: “There has to be a marriage between the drug discovery part and the drug delivery part”

This renowned Blood-Brain Barrier expert attended the Barcelona BioMed Conference in November

Prestigious award for IRB Barcelona video

2015 Prisma prize for best video for "doing away with the stereotypes of scientists, and for its originality and bravery" according to the jury